Literature DB >> 2548892

Dual granule localization of the dormant NADPH oxidase and cytochrome b559 in human neutrophils.

O W Bjerrum1, N Borregaard.   

Abstract

The subcellular localization of the microbicidal nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and associated b-cytochrome was investigated in human neutrophils. In unperturbed neutrophils 85% of b-cytochrome and the major part of membrane-bound components of the NADPH oxidase co-sedimented with markers for specific granules and gelatinase. Using cytochrome b559 as a marker for membrane-bound components of the NADPH oxidase in quantitative studies we observed that, of the remaining 15%, the vast majority co-sedimented with latent alkaline phosphatase, a marker for a newly identified mobilizable intracellular compartment. Only a small fraction co-localized with the plasma membranes. Azurophil granules contained a protease activity which rapidly inactivated the NADPH oxidase components present in other membranes. Stimulation of the neutrophils with formyl-methionyl-leucyl-phenyl-alanine and leukotriene B4 which caused minimal degranulation of specific granules, resulted in translocation of b-cytochrome to the plasma membrane, concomitant with incorporation of alkaline phosphatase into the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548892     DOI: 10.1111/j.1600-0609.1989.tb01254.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  13 in total

1.  Phagocytosis by lipopolysaccharide-primed human neutrophils is associated with increased extracellular release of reactive oxygen metabolites.

Authors:  P Follin; C Dahlgren
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

2.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

3.  A rise in ionized calcium activates the neutrophil NADPH-oxidase but is not sufficient to directly translocate cytosolic p47phox or p67phox to b cytochrome containing membranes.

Authors:  C Movitz; C Sjölin; C Dahlgren
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

4.  An extragranular compartment of blood eosinophils contains eosinophil protein X/eosinophil-derived neurotoxin (EPX/EDN).

Authors:  Malgorzata Karawajczyk; Christer G B Peterson; Per Venge; Rodolfo C Garcia
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 5.  Granules and secretory vesicles of the human neutrophil.

Authors:  N Borregaard; L Kjeldsen; K Lollike; H Sengeløv
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  The serine protease inhibitor diisopropylfluorophosphate inhibits neutrophil NADPH-oxidase activity induced by the calcium ionophore ionomycin and serum opsonised yeast particles.

Authors:  H Lundqvist; C Dahlgren
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

7.  Oxygen metabolites induced by phorbol myristate acetate increase lateral diffusion of wheat germ agglutinin-labeled glycoconjugates in human polymorphonuclear leukocytes.

Authors:  B Johansson; K E Magnusson
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

8.  Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils.

Authors:  H Sengeløv; F Boulay; L Kjeldsen; N Borregaard
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

9.  Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring.

Authors:  H Mundi; B Björkstén; C Svanborg; L Ohman; C Dahlgren
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Stimulus-dependent secretion of plasma proteins from human neutrophils.

Authors:  N Borregaard; L Kjeldsen; K Rygaard; L Bastholm; M H Nielsen; H Sengeløv; O W Bjerrum; A H Johnsen
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.